Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Suspended 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Pain 2Cancer Pain 2Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Pain, Postoperative 1Neoplasm Metastasis 1Multiple Pulmonary Nodules 1Multiple Myeloma 1Lymphoma 1Kidney Neoplasms 1Intra-abdominal Cancer 1Hematologic Neoplasms 1Agnosia 1

Interventions

enzalutamide 92Magnetic Resonance Spectroscopy 87Specimen Handling 66Prednisone 65Androgen Antagonists 59Abiraterone Acetate 59apalutamide 56Radiosurgery 53Radiotherapy 47Leuprolide 47darolutamide 46abiraterone 44Docetaxel 43Radiation 31Pluvicto 31acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 30Biopsy 30relugolix 28Surveys and Questionnaires 28pembrolizumab 26gallium 68 PSMA-11 26Standard of Care 26Triptorelin Pamoate 25Goserelin 25bicalutamide 23Gonadotropin-Releasing Hormone 23Brachytherapy 21Carboplatin 20X-Rays 19luprolide acetate gel depot 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Oxycodone × 1 year × Clear all
NCT05597878 2026-05-26

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Wake Forest University Health Sciences

Phase 2/3 Suspended
100 enrolled
Genitourinary

Agnosia, Prostatic Neoplasms

NCT07001709 2025-06-03

ENABLE

Deventer Ziekenhuis

Phase 4 Recruiting
29 enrolled
Genitourinary

Cancer Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡